Advertisement Holmes signs contract with East Asian pharmaceutical firm - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Holmes signs contract with East Asian pharmaceutical firm

Holmes Biopharma, a provider of clinical development services, has signed a $1.2 million dollar contract with a large East Asian pharmaceutical company.

The contract establishes Holmes Biopharma with another major multinational pharmaceutical company, generating substantial phase I clinical trial revenue for the Omaha operation. Furthermore, this contract is a significant revenue source for Holmes Biopharma’s Data Management Center in Toronto, Canada.

John Metcalfe, president and CEO of Holmes Biopharma, said: “We are just beginning to realize the potential of this highly profitable component of the clinical research business.”